Cargando…

Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery

The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebrón, José Antonio, López-López, Manuel, García-Calderón, Clara B., V. Rosado, Ivan, Balestra, Fernando R., Huertas, Pablo, Rodik, Roman V., Kalchenko, Vitaly I., Bernal, Eva, Moyá, María Luisa, López-Cornejo, Pilar, Ostos, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398082/
https://www.ncbi.nlm.nih.gov/pubmed/34452211
http://dx.doi.org/10.3390/pharmaceutics13081250
_version_ 1783744753046650880
author Lebrón, José Antonio
López-López, Manuel
García-Calderón, Clara B.
V. Rosado, Ivan
Balestra, Fernando R.
Huertas, Pablo
Rodik, Roman V.
Kalchenko, Vitaly I.
Bernal, Eva
Moyá, María Luisa
López-Cornejo, Pilar
Ostos, Francisco J.
author_facet Lebrón, José Antonio
López-López, Manuel
García-Calderón, Clara B.
V. Rosado, Ivan
Balestra, Fernando R.
Huertas, Pablo
Rodik, Roman V.
Kalchenko, Vitaly I.
Bernal, Eva
Moyá, María Luisa
López-Cornejo, Pilar
Ostos, Francisco J.
author_sort Lebrón, José Antonio
collection PubMed
description The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC(12))(4), were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC(12))(4)/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC(12))(4)/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug.
format Online
Article
Text
id pubmed-8398082
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83980822021-08-29 Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery Lebrón, José Antonio López-López, Manuel García-Calderón, Clara B. V. Rosado, Ivan Balestra, Fernando R. Huertas, Pablo Rodik, Roman V. Kalchenko, Vitaly I. Bernal, Eva Moyá, María Luisa López-Cornejo, Pilar Ostos, Francisco J. Pharmaceutics Article The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC(12))(4), were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC(12))(4)/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC(12))(4)/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug. MDPI 2021-08-12 /pmc/articles/PMC8398082/ /pubmed/34452211 http://dx.doi.org/10.3390/pharmaceutics13081250 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lebrón, José Antonio
López-López, Manuel
García-Calderón, Clara B.
V. Rosado, Ivan
Balestra, Fernando R.
Huertas, Pablo
Rodik, Roman V.
Kalchenko, Vitaly I.
Bernal, Eva
Moyá, María Luisa
López-Cornejo, Pilar
Ostos, Francisco J.
Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
title Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
title_full Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
title_fullStr Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
title_full_unstemmed Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
title_short Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
title_sort multivalent calixarene-based liposomes as platforms for gene and drug delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398082/
https://www.ncbi.nlm.nih.gov/pubmed/34452211
http://dx.doi.org/10.3390/pharmaceutics13081250
work_keys_str_mv AT lebronjoseantonio multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT lopezlopezmanuel multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT garciacalderonclarab multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT vrosadoivan multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT balestrafernandor multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT huertaspablo multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT rodikromanv multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT kalchenkovitalyi multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT bernaleva multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT moyamarialuisa multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT lopezcornejopilar multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery
AT ostosfranciscoj multivalentcalixarenebasedliposomesasplatformsforgeneanddrugdelivery